注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户？ 登录
💎 挖掘各大市场被低估的宝藏股
立即进入
BlackRock Global Funds - World Healthscience Fund I2 (0P0001HCA0)
从投资组合添加/删除
添加至投资组合
15.370
+0.030
+0.20%
04/11 - 闭盘. EUR 货币
类型:
基金
市场:
卢森堡
发行商:
BlackRock (Luxembourg) SA
ISIN:
LU1960219571
资产类别:
股票
- 晨星评级:
- 总资产: 1.52B
BlackRock Global Funds - World Healthscience Fund
15.370
+0.030
+0.20%
0P0001HCA0概述
本页面提供BlackRock Global Funds - World Healthscience Fund I2的详细介绍，帮助您了解0P0001HCA0的高管、总资产、投资策略和联系方式等信息。
投资策略
世界健康科学基金以尽量提高总回报为目标，并以贯彻环境、 社会及管治（「ESG」）投资原则的方式进行投资。基金将其 至少70%的总资产投资于全球各地主要经济活动从事保健、 制药及医学科技及生物科技供应及开发业务的公司的股本证 券。基金是互联互通基金，可透过互联互通机制最多以其总资产 的20%直接投资于中国。
联络信息
地址
35 A, avenue J.F. Kennedy,
Luxembourg, L-1855
Luxembourg
Luxembourg, L-1855
Luxembourg
电话
+44 20 77433000
传真
Amsterdam
高管
| 名称 | 标题 | 任期 | 至 |
|---|---|---|---|
| Xiang Liu | Director | 2020 | now |
| 背景介紹 | Xiang Liu, PhD, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the medical devices & supplies sector. Prior to joining BlackRock in 2008, Mr. Liu was a partner and biotech analyst at Mehta Partners. From 2002 to 2005, he was a Director in the corporate development department at Cubist Pharmaceuticals. Mr. Liu began his investment career in 2000 at the Boston Consulting Group as a Healthcare consultant. Mr. Liu earned a BS degree in Chemistry from the University of Science & Technology, China in 1993, a PhD degree in Chemistry from Yale University in 1997, and a MBA degree in finance, strategy, and accounting from the University of Chicago in 2000. | ||
| Erin Xie | Managing Director | 2011 | now |
| 背景介紹 | Erin Xie, PhD, Managing Director and portfolio manager, is the head of the Health Sciences team, part of BlackRock’s Active Equity Group. She is the lead portfolio manager for the Health Sciences equity portfolios. Ms. Xie's service with the firm dates back to 2001, including her years with State Street Research & Management (SSRM), which merged with BlackRock in 2005. At SSRM, she was a Senior Vice President and portfolio manager responsible for managing the State Street Health Sciences Fund. Prior to joining State Street Research in 2001, Ms. Xie was a research associate with Sanford Bernstein covering the pharmaceutical industry from 1999. From 1994 until 1997, she was a post doctoral research scientist at Columbia University. Ms. Xie earned a BS degree in chemistry from Beijing University in 1988, a PhD degree in Biochemistry from the University of California, Los Angeles, in 1993 and a MBA degree from the Massachusetts Institute of Technology Sloan School of Management in 1999. | ||
| Jeff Lee | - | 2020 | 2023 |
| 背景介紹 | Jeffrey Lee, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the healthcare providers and services sector. Prior to joining BlackRock in 2011, Mr. Lee was a member of the healthcare investment team at Duquesne Capital Management where he covered provider and service companies. From 2006 to 2008, Mr. Lee was an healthcare private equity associate at Altaris Capital Partners where he sourced and analyzed equity transactions for public and private healthcare companies. Prior to 2006, Mr. Lee was an analyst at Citigroup within the healthcare finance and investment banking group where he valued and helped structured financing for managed care providers, hospital companies and other large healthcare systems. Mr. Lee earned a BA degree in economics, cum laude, from Princeton University in 2004. | ||
| Thomas P. Callan | Managing Director | 2011 | 2017 |
| 背景介紹 | Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981. | ||
| Bob Hodgson | - | 2005 | 2011 |
写出您对于 BlackRock Global Funds - World Healthscience Fund I2 的看法
确定删除此图表？
删除 取消
用新图表更换现在所附的图表？
更换 取消
评论指南
在评论中添加图表
确认屏蔽
确定屏蔽%USER_NAME%？
如果屏蔽，您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人，因此必须等待48小时才能重新屏蔽。
举报该评论
您举报该评论的原因为：
该评论已被标注
谢谢您!
您的举报将会被发送到管理员进行审核